Clinical trials
Ovarian Neoplasms trials in Australia with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immix Biopharma Australia Pty Ltd | 1 |
| Multitude Therapeutics Inc. | 1 |
| National University Hospital, Singapore | 1 |
| Peter MacCallum Cancer Centre, Australia | 1 |
| Sabine Rhode | 1 |
| University College, London | 1 |
| Walter and Eliza Hall Institute of Medical Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 7 |
| Fallopian Tube Neoplasms | 2 |
| Mesothelioma, Malignant | 2 |
| Pancreatic Neoplasms | 2 |
| Adenocarcinoma of Lung | 1 |
| Appendiceal Neoplasms | 1 |
| Ascites | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.